The study aims to compare the effectiveness of A+AVD and PET-guided ABVD in treating advanced Hodgkin lymphoma.
Matching-adjusted indirect treatment comparison (MAIC) applied to two treatment regimens.
Evaluation of adult patients diagnosed with advanced Hodgkin lymphoma.
Comparison against outcomes from RATHL and SWOG S0816 studies.
A+AVD demonstrated durable treatment benefits over PET-guided regimens.
Findings indicate improved patient outcomes with A+AVD in the studied population.
Abstract
MAIC results indicated durable A+AVD treatment benefits in adults with newly diagnosed advanced Hodgkin lymphoma versus PET-guided regimens evaluated in RATHL and SWOG S0816.